Your browser doesn't support javascript.
loading
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada, Kazuyuki; Yamaguchi, Motoko; Atsuta, Yoshiko; Matsue, Kosei; Sato, Keijiro; Kusumoto, Shigeru; Nagai, Hirokazu; Takizawa, Jun; Fukuhara, Noriko; Nagafuji, Koji; Miyazaki, Kana; Ohtsuka, Eiichi; Okamoto, Masataka; Sugita, Yasumasa; Uchida, Toshiki; Kayukawa, Satoshi; Wake, Atsushi; Ennishi, Daisuke; Kondo, Yukio; Izumi, Tohru; Kin, Yoshihiro; Tsukasaki, Kunihiro; Hashimoto, Daigo; Yuge, Masaaki; Yanagisawa, Atsumi; Kuwatsuka, Yachiyo; Shimada, Satoko; Masaki, Yasufumi; Niitsu, Nozomi; Kiyoi, Hitoshi; Suzuki, Ritsuro; Tokunaga, Takashi; Nakamura, Shigeo; Kinoshita, Tomohiro.
Afiliação
  • Shimada K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: kshimada@med.nagoya-u.ac.jp.
  • Yamaguchi M; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Matsue K; Division of Hematology/Oncology, Internal Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Sato K; Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Takizawa J; Department of Hematology, Endocrinology and Metabolism, Niigata University Faculty of Medicine, Niigata, Japan.
  • Fukuhara N; Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan.
  • Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Miyazaki K; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
  • Ohtsuka E; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Okamoto M; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Sugita Y; Department of Hematology, Oami Municipal Hospital, Oamishirasato, Japan.
  • Uchida T; Department of Hematology and Oncology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan.
  • Kayukawa S; Department of Clinical Oncology, Nagoya Memorial Hospital, Nagoya, Japan.
  • Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.
  • Ennishi D; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
  • Kondo Y; Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan.
  • Izumi T; Division of Hematology, Tochigi Cancer Center, Utsunomiya, Japan.
  • Kin Y; Department of Hematology, Daini Osaka Police Hospital, Osaka, Japan.
  • Tsukasaki K; Department of Hematology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Hashimoto D; Department of Hematology, Hokkaido University Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan.
  • Yuge M; Division of Hematology, Ichinomiya Municipal Hospital, Ichinomiya, Japan.
  • Yanagisawa A; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Kuwatsuka Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Shimada S; Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan.
  • Masaki Y; Department of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan.
  • Niitsu N; International Medical Center, Saitama Medical University, Hidaka, Japan.
  • Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Suzuki R; Department of HSCT Data Management and Biostatistics, Nagoya University School of Medicine, Nagoya, Japan.
  • Tokunaga T; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Nakamura S; Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan.
  • Kinoshita T; Division of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Lancet Oncol ; 21(4): 593-602, 2020 04.
Article em En | MEDLINE | ID: mdl-32171071
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Metotrexato / Linfoma Difuso de Grandes Células B / Neoplasias Vasculares / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Metotrexato / Linfoma Difuso de Grandes Células B / Neoplasias Vasculares / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article